Literature DB >> 22728955

Rhabdomyolysis as a potential complication of carbamazepine-induced toxic epidermal necrolysis.

Li-Yen Huang1, Chih-Ming Lin, Chien-Chun Chiou, Wei-Shiang Lin, Shu-Meng Cheng.   

Abstract

Toxic epidermal necrolysis (TEN) is a rare and severe exfoliative skin disorder characterized as widespread epidermis destruction and is usually a drug-induced condition. TEN has a high mortality rate, and multisystemic involvement is very frequent. Gastrointestinal, respiratory, hepatic, pancreatic, ocular, and hematological disturbances are common complications of TEN. Here, we report on a 30-year-old male with TEN who developed concurrent rhabdomyolysis. The exact relationship between TEN and rhabdomyolysis remains unknown. Because of lack of underlying etiology, we hypothesized that rhabdomyolysis is a potential TEN-related complication.
Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728955     DOI: 10.1016/j.clinbiochem.2012.06.008

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  3 in total

Review 1.  Rhabdomyolysis Induced by Isoniazid in a Patient with Rheumatoid Arthritis and End-stage Renal Disease: A Case Report and Review of the Literature.

Authors:  Toshihiko Komai; Shuji Sumitomo; Shuzo Teruya; Keishi Fujio
Journal:  Intern Med       Date:  2018-03-09       Impact factor: 1.271

2.  A Novel Compound Heterozygous CYP17A1 Variant Causes 17α-Hydroxylase/17, 20-Lyase Deficiency.

Authors:  Hong Chen; Ke Yuan; Bingtao Zhang; Zexiao Jia; Chun Chen; Yilin Zhu; Yaping Sun; Hui Zhou; Wendong Huang; Li Liang; Qingfeng Yan; Chunlin Wang
Journal:  Front Genet       Date:  2019-10-22       Impact factor: 4.599

3.  Rhabdomyolysis presenting with severe hypokalemia in hypertensive patients: a case series.

Authors:  Zhang Wen; Li Chuanwei; Zeng Chunyu; Huang Hui; Li Weimin
Journal:  BMC Res Notes       Date:  2013-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.